Form 144 Cellebrite DI Ltd. Filed by: Carmil Yosef
Cellebrite DI Ltd. - Ordinary Shares (CLBT)
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
CLBT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLBT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLBT alerts
High impacting Cellebrite DI Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
CLBT
News
- Cellebrite Announces Availability of Industry-Leading Endpoint Inspector SaaS Solution on Amazon Web Services MarketplaceGlobeNewswire
- Leopard Asset Management Urges Sun Corporation’s Shareholders to Hold Management Accountable for Their Failure to Achieve Their Own Stated Goals of Increasing Shareholder ValueBusiness Wire
- Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at JPMorgan Chase & Co. from $12.00 to $14.00. They now have an "overweight" rating on the stock.MarketBeat
- Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at Needham & Company LLC from $13.50 to $14.00. They now have a "buy" rating on the stock.MarketBeat
- Cellebrite DI Ltd. (CLBT) Q1 Earnings and Revenues Surpass Estimates [Yahoo! Finance]Yahoo! Finance
CLBT
Earnings
- 5/23/24 - Beat
CLBT
Sec Filings
- 6/12/24 - Form 144
- 6/11/24 - Form 144
- 6/11/24 - Form 144
- CLBT's page on the SEC website